AzTrials
AzTrials

Muscle PerformanceNCT07379385

Effects of Weekly Set Volume on Muscle Adaptation

A study testing Low volume (LV), Moderate Volume (MV) and High Volume (HV) in people with Muscle Performance and Resistance Training, run by Universidade Norte do Paraná at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The progressive loss of strength and muscle mass is a natural aging process, with direct implications for functional capacity. Resistance training (RT) is considered the main intervention to counteract this decline. Read more about this study

Who is it for?
Ages 65 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Performance, Resistance Training
What is being tested?
Low volume (LV), Moderate Volume (MV) and High Volume (HV)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
57 participants
Where
1 siteBrazil
Study dates
1 Jan 2026to 10 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age between 65 and 80 years

Who cannot join

  • not having used any medication or substance that affects or improves muscle function for at least 3 months prior to the study,
  • having any physical or physiological limitation that may affect the ability to perform the tests and physical training,
  • not being able to understand the informed consent form and study procedures.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Northern University of Paraná

    Londrina, Paraná, 86047-622

Other trials in Brazil

About this study

Official title: The Effect of Weekly Set Volume of Resistance Training on Strength and Hypertrophy

The progressive loss of strength and muscle mass is a natural aging process, with direct implications for functional capacity. Resistance training (RT) is considered the main intervention to counteract this decline. Although the RT guidelines are well established, the ideal weekly set volume to maximize strength and hypertrophy gains in older adults remains unknown. The purpose of this study is to investigate the effects of different volumes of weekly sets of RT on muscle strength and hypertrophy in older adults

Read the detailed description

BACKGROUND: The progressive loss of strength and muscle mass is a natural process of aging, with direct implications for functional capacity. Resistance training (RT) is considered the main intervention to counteract this decline. Although RT guidelines are well established, the ideal weekly volume of sets to maximize strength and hypertrophy gains in older adults remains unknown. PURPOSE: To investigate the effects of different weekly RT volumes on lower limb muscle strength and hypertrophy (quadriceps femoris) in older adults. METHODS: Fifty-seven older adults of both sexes will be matched for maximum dynamic strength (one repetition maximum - 1RM) and randomly divided into 03 groups: [Low Volume (LV = 6 sets/week, n = 19), Moderate Volume (MV = 18 sets/week, n = 19) and High Volume (LV = 30 sets/week, n = 18)]. All participants will undergo a 10-week resistance training protocol (3x/week), consisting of 8 exercises: bench press, leg press, seated row, leg extension, bicep curl, leg curl, triceps pulley, and seated calf raise. Only the leg extension and leg press exercises will be performed with different volumes of sets (VB = 1 set/exercise; VM = 3 sets/exercise; VA = 5 sets/exercise). The number of repetitions per set will be 8-12, and the training load will be adjusted every two weeks based on the maximum number of repetitions performed in the last training session. The following dependent variables will be analyzed before and after the training program: (1) maximum dynamic strength (1RM) and (2) maximum voluntary isometric contraction (MVIC) in the leg extension exercise, (3) muscle hypertrophy (thickness) of the quadriceps muscle and rectus femorisusing ultrasound images, and (4) rating of perceived exertion (RPE) and (5) affective responses (pleasure and displeasure) after training sessions. Data will be tested for normality and homogeneity using the Shapiro-Wilk's and Levene's tests, respectively. Changes over time and between groups will be analyzed with two-way repeated measures ANOVA tests. Violation of sphericity was corrected using the Greenhouse-Geisser method. When significant differences will be confirmed with the ANOVA, multiple comparison testing will be performed using the Bonferroni post hoc correction to identify these differences. Values will be expressed as mean (standard deviation and 95% confidence interval). The significance level was set at p < 0.05.

Being tested
Low volume (LV), Moderate Volume (MV), High Volume (HV)
Keywords
Resistance exercise, Weekly set volume, Training volume, Muscle hypertrophy, Muscle strength, Aging

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low volume (LV)Other

    Participants will be performed 6 sets/week during 10 weeks

  • Moderate Volume (MV)Other

    Participants will be performed 18 sets/week during 10 weeks

  • High Volume (HV)Other

    Participants will be performed 30 sets/week during 10 weeks

Study groups in NCT07379385
Study groupRoleWhat they receive
Low Volume (LV)ExperimentalParticipants will be performed 6 sets/week
Receives: Other: Low volume (LV)
Moderate Volume (MV)ExperimentalParticipants will be performed 18 sets/week
Receives: Other: Moderate Volume (MV)
High Volume (HV)ExperimentalParticipants will be performed 30 sets/week
Receives: Other: High Volume (HV)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum dynamic strength (1RM)

    The one-repetition maximum test will be performed on a bilateral leg extension machine. Briefly, participants will undergo 3 test attempts, interspersed with 5-minute intervals. Loads of 10-15% will be added after each attempt in order to reach the 1RM load within the 3 trials. Participants will be verbally encouraged during each attempt.

    Measured: baseline and after 10 weeks of intervention

  2. Maximum voluntary isometric contraction (MVIC)

    The MVIC test for the leg extension exercise (bilateral) will be performed using an isometric dynamometer (CEFISE Biotechnology, São Carlos, Brazil). Briefly, participants will perform three MVICs at 120º of knee flexion (180º = full extension) lasting 5 s, interspersed with 5 s of rest. Participants will be instructed and verbally encouraged to exert maximum force during all attempts. The highest value obtained for peak and mean torque of the three MVICs will be used for the analysis.

    Measured: baseline and after 10 weeks of intervention

  3. Muscle hypertrophy (thickness)

    Muscle hypertrophy (thickness) of the quadriceps and rectus femoris muscles will be assessed using ultrasound images obtained at 3 anatomical points (30, 50, and 60% of the distance between the greater trochanter of the femur and the knee joint line). Muscle thickness will be analyzed using the image analysis program (ImageJ®).

    Measured: baseline and after 10 weeks of intervention

Secondary outcomes (2)
  1. Rating of perceive exterion (RPE)

    Rating of perceived exertion (RPE) will be recorded immediately after completion of each set using the OMNI-RES scale. The participants will be instructed to report the perceived exertion value by indicating a number on the OMNI-RES scale (0 for ''no effort'' and 10 for ''maximal effort'') that best represented their momentary exertion.

    Measured: Immediately after completion of each set of exercise

  2. Affective responses (pleasure and displeasure)

    The affective response will be assessed using an 11-point affectivity scale, ranging from +5 to -5, with a score of zero considered neutral, positive numbers (+1 to +5) representing feelings of pleasure, and negative numbers (-1 to -5) representing feelings of displeasure.

    Measured: Immediately after each exercise during training sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start1 Jan 2026
  3. Primary completion6 Apr 2026
  4. Study completion10 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07379385
Sponsor's protocol ID
Weekly set volume study
Status last verified
Sep 2026
First submitted
7 Jan 2026
Last updated
9 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Robertson RJ, Goss FL, Rutkowski J, Lenz B, Dixon C, Timmer J, Frazee K, Dube J, Andreacci J. Concurrent validation of the OMNI perceived exertion scale for resistance exercise. Med Sci Sports Exerc. 2003 Feb;35(2):333-41. doi: 10.1249/01.MSS.0000048831.15016.2A.

    PubMed 12569225

Questions about this trial

What is this clinical trial studying?

A study testing Low volume (LV), Moderate Volume (MV) and High Volume (HV) in people with Muscle Performance and Resistance Training, run by Universidade Norte do Paraná at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum dynamic strength (1RM) (time frame: baseline and after 10 weeks of intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07379385, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in